Clinical Study

A Phase 2 Randomized Study Of Efatutazone, An Oral Ppar Agonist, In Combination With Paclitaxel Versus Paclitaxel In Patients With Advanced Anaplastic Thyroid Cancer

Posted Date: Oct 8, 2014

  • Investigator: Nooshin Hashemi Sadraei
  • Co-Investigator: Null Null
  • Specialties: Hematology/Oncology, Oncology, Cancer, Head & Neck Cancer
  • Type of Study: Drug

The purpose of this study is to compare any good and bad effects of using efatutazone along with the usual chemotherapy to using the usual chemotherapy alone.


To Be Eligible For This Study, Patients Must Have Anaplastic Thyroid Cancer Which Cannot Be Removed With Surgery Or Has Spread To Other Areas Of The Body.


Advanced Anaplastic Thyroid Cancer, Thyroid Cancer, A091305, Cancer, Head & Neck, 2014-5243

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Enhanced Recovery Program for Colorectal Surgery Patients Reduces Costs

    A standardized protocol for managing patients for the duration of colorectaloperations not only improved clinical outcomes, but also it significantlyreduced hospital costs.